Genomic Research Partnerships New York Genome Center is collaborating with renowned institutions like The Broad Institute of MIT and Harvard and UCLA to develop the BD 2 Genetics Platform, presenting a sales opportunity for strategic partnerships with cutting-edge research initiatives.

Clinical Genomics Initiatives With the launch of the MacMillan Center for the Study of the Non-Coding Cancer Genome, there is a sales opportunity to offer genomic analysis services tailored for cancer research programs focusing on non-coding genomic regions in various cancer types.

Disease-Specific Sequencing Collaborating with programs like Autism BrainNet for brain donation sequencing and receiving awards for ALS research positions New York Genome Center for sales in disease-specific sequencing services, catering to specialized research needs.

COVID-19 Genomics Network The establishment of the COVID-19 Genomics Research Network highlights a sales opportunity to provide sequencing solutions for large-scale virus spread analysis and research, presenting a timely and critical service offering in pandemic preparedness.

High-Quality Sequencing Capabilities Given New York Genome Center's strong capabilities in whole-genome sequencing and genomic analysis, there is a sales opportunity to provide high-quality sequencing services to other research institutions looking to enhance their genomic research outputs and capabilities.